PTSD Trial, Recruiting NCT07401225 Sponsor: The University of Texas Health Science Center at San Antonio Condition: PTSD
Back to Ptsd

PTSD Trial, Recruiting

NCT07401225
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 12 to 20 years old, of any gender
  • People who have already completed at least 9 sessions of trauma-focused therapy, either through a clinical trial or in the community
  • People whose current PTSD symptom score is 20 or higher on a standard self-reported questionnaire called the UCLA PTSD Reaction Index (confirm with trial site)
  • People who are able to attend 10 treatment sessions within a 30-day period
  • People who are fluent in English

Who may not be able to join:

  • People with a history of seizures
  • People who have had a head injury that caused loss of consciousness or ongoing concussion-related effects
  • People with a known brain abnormality, such as a tumour or other detectable brain condition
  • People who are currently receiving any form of talking therapy or TMS (a type of brain stimulation treatment)
  • People who are currently pregnant
  • People who have metal in their body or orthodontic braces, as these are not compatible with MRI scanning
  • People who have been diagnosed with bipolar 1 disorder or a psychotic disorder

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 6 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Amy S Garrett, PhD, The University of Texas Health Science Center at San Antonio

Phone: 210-567-8189

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
The University of Texas Health Science Center at San Antonio
Registry
ClinicalTrials.gov
Start date
9 May 2026
Est. completion
1 June 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Side Effects of TMS treatment; Number of Adverse Events; Completion rate of Treatment

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov